Summary
Cryptococcal meningitis in AIDS patients is liable to relapse and carries a high mortality rate. Standard treatment with amphotericin B and 5-fluorocytosine is limited by toxic effects. In the present study 64 AIDS patients with cryptococcal meningitis were admitted to a multicentre trial of fluconazole given either orally or intravenously. After a loading dose of 400 mg, two dosage regimens were adopted: 150–200 mg, or 400 mg daily for at least 45–60 days; subsequent maintenance therapy was 100 or 200 mg daily for both groups. Forty seven of the 52 evaluable patients were alive and improved or asymptomatic at day 60 and respectively 7 of 14 and 27 of 31 of those on 200 mg or 400 mg per day had negative cultures of the cerebrospinal fluid. Relapse rate under maintenance therapy was 23%. Fluconazole was well tolerated and free from severe side effects. These results merit further study of fluconazole, either alone or in combination.
(M. Armengaud, J.P. Bleriot, J.P. Brion, G. Calamy, A. Chapman, J.P. Coulaud, P. de Truchis, G. Humbert, C. Lafaix, J. Modai, M. Obadia, O. Patey, J. Prinseau, F. Raffi, W. Rosenbaum, R. Roue, F. Vachon, A. Vergnenegre)
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Bennett, J.E., Dismukes, W.E., Duma, T.R. et al., 1975, A comparison of amphotericin B alone and combined with flucytosine in the treatment of cryptococcal meningitis, N. Engl. J. Med., 301:126.
Byrne, W.R., and Wajszczuk, C.P., 1988, Cryptococcal meningitis in AIDS: successful treatment with fluconazole after failure of amphotericin B, Ann. Intern. Med., 108:384.
Chuck, S.L., and Sande, M.A., 1989, Infections with Cryptococcus neoformans in the acquired immunodeficiency syndrome, N. Engl. J. Med., 21:794.
Dismukes, W.E., 1988, Cryptococcal meningitis in patients with AIDS, J. Infect. Dis., 157:624.
Dismukes, W., Cloud, G., Thompson, S., Sugar, A. et al., NIAID mycoses study group, 1989, Fluconazole versus amphotericin B therapy of acute cryptococcal meningitis, Abstract No. 1065, ICAAC.
Dupont, B., and Drouhet, E., 1987, Cryptococcal meningitis and fluconazole, Ann. Intern. Med., 106:778.
Eng, R.H.K., Bishburg, E., Smith, S.M., and Kapila, R., 1986, Cryptococcal infections in patients with acquired immune deficiency syndrome, Am. J. Med., 81:19.
Gans de, J., Eeftinck Schattenkerk, J.K.M., and Ketel, V.R.J., 1988, Itraconazole as maintenance treatment for crytococcal meningitis in the acquired immune deficiency syndrome, Br. Med. J., 296.
Graybill, J.R., 1987, Fluconazole efficacy in animal models of mycotic diseases, in: “Recent Trends in the discovery, Development and Evaluation of Antifungal Agents”, R.A. Fromtling, ed., Prous Science, Barcelona.
Katlama, C., Leport, C., Matheron, S. et al., 1984, Acquired immunodeficiency syndrome in Africans, Ann. Soc. Belge Med. Trop., 64:379.
Kovacs, J.A., Kowacs, A.A., Polis, M. et al., 1985, Cryptococcosis in the acquired immunodeficiency syndrome, Ann. Intern. Med., 103:533.
Larsen, R.A., and Leal, M.E., 1989, Fluconazole compared to amphotericin B as treatment of cryptococcal meningitis, Abstract No. 10 62, ICAAC.
Perfect, J.R., Savani, D.V., and Durack, D.T., 1986, Comparison of itraconazole and fluconazole in treatment of cryptococcal meningitis and candida pyelonephritis in rabbits, Antimicrob. Agents Chemother., 29:579.
Piot, P., Taelman, H., Rapita, B.M. et al., 1984, Acquired immunodeficiency syndrome in a heterosexual population in Zaire, Lancet, 2:65.
Stern, J.J., Hartman, B.J., Sharkey, P., Rowland, V., Squires, K.E., Murray, H.W., and Graybill, R., 1988, Oral fluconazole therapy for patients with acquired immunodeficiency syndrome and cryptococcosis: experience with 22 patients, Am. J. Med., 85:477.
Sugar, A.M., and Saunders, C., 1988, Oral fluconazole as suppressive therapy of disseminated cryptococcosis in patients with acquired immunodeficiency syndrome, Am. J. Med., 85:481.
Van Cutsem, J., Van Gerven, F., and Janssen, P.A.J., 1987, The in vitro and in vivo antifungal activity of itraconazole, in: “Recent Trends in the Discovery, Development and Evaluation of Antifungal Agents”, R.A. Fromtling, ed., Prous Science, Barcelona.
Van ‘t Wout, J.W., de Graeff-Meeder, E.R., Paul, L.C., Kuis, W., and Van Furth, R., 1988, Treatment of two cases of cryptococcal meningitis with fluconazole, Scand. J. Infect. Dis., 20:193.
Viviani, M.A., Tortorana, A.M., and Giani, P.C., 1987, Itraconazole for cryptococcal infection in the acquired immunodeficiency syndrome, Ann. Intern. Med., 106.
Zuger, A., Lonie, E., Molzmann, R.S., Simberkoff, M.S., and Rahal, J.J., 1988, Cryptococcal disease in patients with the acquired immunodeficiency syndrome, Ann. Intern. Med., 104:234.
Author information
Authors and Affiliations
Consortia
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1990 Plenum Press, New York
About this chapter
Cite this chapter
Dupont, B. et al. (1990). Cryptococcal Meningitis in AIDS Patients A Pilot Study of Fluconazole Therapy in 52 Patients. In: Bossche, H.V., Mackenzie, D.W.R., Cauwenbergh, G., Van Cutsem, J., Drouhet, E., Dupont, B. (eds) Mycoses in AIDS Patients. Springer, Boston, MA. https://doi.org/10.1007/978-1-4613-0655-9_27
Download citation
DOI: https://doi.org/10.1007/978-1-4613-0655-9_27
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4612-7912-9
Online ISBN: 978-1-4613-0655-9
eBook Packages: Springer Book Archive